Morgan Stanley Armata Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 426 shares of ARMP stock, worth $1,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares

426

Previous 2 21200.0%

Holding current value

$1,077

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.81 - $4.18 $1,191 - $1,772	424 Added 21200.0%	426 $1,000
Q1 2023 May 15, 2023	SELL	$1.1 - $3.58 $13 - $42	-12 Reduced 85.71%	2 $0
Q4 2022 Feb 14, 2023	BUY	$0.94 - $3.28 $12 - $42	13 Added 1300.0%	14 $0
Q3 2022 Nov 14, 2022	SELL	$3.12 - $4.92 $3,338 - $5,264	-1,070 Reduced 99.91%	1 $0
Q1 2022 May 13, 2022	SELL	$3.9 - $6.32 $54 - $88	-14 Reduced 1.29%	1,071 $5,000

Q4 2021 Feb 14, 2022	SELL	$2.96 - $5.86 $171 - $339	-58 Reduced 5.07%	1,085 $6,000
Q3 2021 Nov 15, 2021	BUY	$3.55 - $4.14 $4,057 - $4,732	1,143 New	1,143 $4,000

Others Institutions Holding ARMP

# of Institutions

Shares Held

1.42M

Call Options Held

200

Put Options Held

View Full List

About Armata Pharmaceuticals, Inc.

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $91.4M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

More about ARMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account